✨ FathomX founders and National University of Singapore professors Mengling 'Mornin' Feng and Mikael Hartman featured by NUHS: "How deep tech is revolutionising mammogram screening. Powered by artificial intelligence, a novel tool called FxMammo holds promise for better, faster and smarter breast cancer detection." "FxMammo is the flagship product of FathomX, a medtech company spun off from the National University of Singapore (NUS) and the National University Health System (NUHS). A/Prof Mikael Hartman, Head and Senior Consultant, Division of General Surgery (Breast Surgery), Department of Surgery, NUH, developed FxMammo in collaboration with A/Prof Feng Mengling from the NUS Saw Swee Hock School of Public Health (SSHSPH). Together, they co-founded FathomX to commercialise this innovative solution." #AI #medicalimaging #radiology #breastcancer #femalehealth https://lnkd.in/dQRJe9Q3
